RESTLESS LEGS SYNDROME AND PERIODIC LIMB MOVEMENT DISORDER
Mirapex is a medication used to treat Parkinson’s disease and restless legs syndrome (RLS). Buy mirapex restless leg syndrome and feel better today!
Question:
You’re welcome… I’m going through hell right now because I am 21 weeks pregnant and the combination of hormone changes and my blood volume increasing (thus using up lots of my iron) is making my life a living hell. I spend 11 hours a night in bed and still wake up exhausted every day. My PLMD medicine Mirapex is unknown if it’s safe in pregnancy so I take the smallest amount I can get by on. But sometimes my lack of sleep gets so bad that it leads to depression and anxiety. I keep having to increase my medicine Mirapex just to get the same level of exhaustion in the mornings as my blood volume and metabolism continue to increase. I do take iron when I can but my Mirapex and my pregnancy both make me nauseous. I did not throw up once with my first pregnancy but now here I am at 21 weeks and I still am throwing up every other morning. The Mirapex and the exhaustion make the nausea much worse. The Mirapex also causes my nose to totally stop up every night about one hour after I take it. My nose stuffs up with out my having to lay down. I can not sleep at all when my nose is totally blocked and my saline irrigation with my water pic and grossan tip does not help at all for this. As a result I’ve been having to use OTC nose spray every night.. that is a very bad thing but I make it a little better by only using one squirt in one nostril each night so each side of my nose gets almost a 48 hour break between doses.. but still it’s all connected up there and I do find myself needing more nose spray.. but I am also needing more Mirapex and that adds to the stuffiness. Last two nights I gave up and increased my dose yet again. now taking 3.25 mg of Mirapex at night.. pre pregnancy I got by on .5 mg. I’m going to have to see my neurologist.. maybe he can give me ambien as it is a safer class drug for pregnancy and if I take it maybe I can cut back a bit on the Mirapex. My lack of sleep is causing me to be sick and depressed. My whole family got infected with C. Jejuni thanks to our puppy, my daughter got over it in one day, my husband got over it in three days but I’m still fighting it 9 days later and am having to take anti-biotics for it. I just can not fight off illness very well when I am this sleep deprived. On Tue, 21 Oct 2003 11:34:08 GMT, "Lis" <liont…@ptd.net> alt.support.sleep-disorder : – Hide quoted text — Show quoted text ->Thanks for the info. Anything that helps….. >Cheers >Lis ><nos…@nospam.com> wrote in message >news:ats2pv8nvsjhqpqal3s8kprmege05bbrlf@4ax.com… >> you only absorb about 10% of the Iron in a standard multi vitamin and >coffee cuts you Iron >> absorbtion by 50%. Try something like Generic Niferex to really boost >your iron level. Best to get >> your serum Ferritin checked before or shortly after you start iron therapy >though. >> Hemoglobin levels of iron MEAN ABSOLUTELY NOTHING when it comes to PLMD. >Many doc’s do not >> understand this. You must know you IRON STORAGE LEVELS as measured by >serum ferritin. My >> hemoglobin levels are always fine thanks to my Niferex but my serum >Ferritin was only 16 when it was >> measured. For PLMD they want you to get that level to 50. 20 is >considered normal. >> On Sat, 18 Oct 2003 12:24:35 GMT, "Lis" <liont…@ptd.net> >alt.support.sleep-disorder : >> >You know, that’s really interesting about the iron connection….I was >> >severely anemic as a child………. Time to get out the old >mulit-vitamins, >> >I suppose… >> >I REALLY hope someone bites and does a decent study, and we get some >benefit >> >out of it. Not looking forward to that "gets worse in old age" thing. I’m >> >only 41, fer gosh sakes. >> >Lis >> ><nos…@nospam.com> wrote in message >> >news:qlc1pvce33n46eers1edu97gijtqenrk7f@4ax.com… >> >> RESTLESS LEGS SYNDROME AND PERIODIC LIMB MOVEMENT DISORDER >> >> The National Institute of Neurological Disorders and Stroke (NINDS), >the >> >> National Institute on Aging (NIA), the National Heart, Lung, and Blood >> >> Institute, and the National Institute of Mental Health (NIMH) encourage >> >> investigator-initiated research grant applications to study restless >> >> legs syndrome (RLS) and periodic limb movement disorder (PLMD). The >> >> etiologies of these disorders are unknown, although there is evidence >> >> that central dopamine mechanisms are involved. Research should be aimed >> >> at an understanding of the pathogenesis of RLS and PLMD that will lead >> >> to new forms of treatment. The intent of this announcement is to >> >> intensify investigator-initiated research, to attract new investigators >> >> to the field, and to enhance interdisciplinary approaches to research >in >> >> these areas. >> >> RESEARCH OBJECTIVES >> >> Background >> >> Restless legs syndrome is a common neurological disorder characterized >> >> by unpleasant sensations of the legs and an urge to move them for >> >> relief. Because symptoms are intensified by inactivity and lying down, >> >> RLS patients often have difficulty falling asleep and staying asleep. >> >> Left untreated, RLS causes exhaustion and fatigue, which can affect >> >> occupational performance, social activities, and family life. Most >> >> prevalence estimates are around 2-5% of the population, although many >> >> more may be affected because the disorder is often not diagnosed. >Severe >> >> RLS is more common in the elderly, affecting an estimated 10-11%, >> >> although symptoms may develop at any age. The etiology of RLS probably >> >> involves central dopamine mechanisms, and both dopaminergic agents and >> >> dopamine agonists have been used to treat symptoms. RLS is also >> >> associated with iron deficiency, indicated by low ferritin levels. >These >> >> levels appear to follow a circadian cycle, and are at their lowest at >> >> night when RLS symptoms are the worst. The frequency of RLS during late >> >> stage pregnancy is increased, which may be related to iron deficiency. >> >> Many people with RLS report a family history of the disorder, but the >> >> exact mode of inheritance is unknown. >> >> It has been estimated that about 80% of RLS patients also have periodic >> >> limb movement disorder (PLMD), or nocturnal myoclonus, which is >> >> characterized by repetitive stereotyped movements of the limbs, >> >> primarily the legs, during sleep. These movements typically occur every >> >> 20 to 40 seconds, and may be associated with repeated arousal, and >> >> severely fragmented sleep. In a study of patients with insomnia, PLMD >or >> >> RLS was diagnosed in 33% of patients older than 60 years as compared to >> >> 18% of those 40 to 60 years and 7% of those 20 to 40 years of age. Like >> >> RLS, the etiology of PLMD may involve a central dopamine mechanism, >> >> because it also responds to dopaminergic drugs. However, treatment >with >> >> dopaminergic agonists can augment the symptoms, possibly by a >> >> continuation of the underlying progressive inhibition of dopaminergic >> >> neuronal activity. Current investigations indicate that both RLS and >> >> PLMD occur in a substantial number of patients suffering from >> >> Parkinson’s disease and narcolepsy, two other disorders thought to >> >> involve central dopamine mechanism. Greater understanding of the role >of >> >> dopamine systems in the etiology of these all of these disorders may >> >> provide a key to new treatment and prevention strategies.
Response:
Thanks for the info. Anything that helps….. Cheers Lis <nos…@nospam.com> wrote in message
news:ats2pv8nvsjhqpqal3s8kprmege05bbrlf@4ax.com… > you only absorb about 10% of the Iron in a standard multi vitamin and
coffee cuts you Iron > absorbtion by 50%. Try something like Generic Niferex to really boost
your iron level. Best to get > your serum Ferritin checked before or shortly after you start iron therapy though. > Hemoglobin levels of iron MEAN ABSOLUTELY NOTHING when it comes to PLMD. Many doc’s do not > understand this. You must know you IRON STORAGE LEVELS as measured by serum ferritin. My > hemoglobin levels are always fine thanks to my Niferex but my serum
Ferritin was only 16 when it was > measured. For PLMD they want you to get that level to 50. 20 is considered normal. > On Sat, 18 Oct 2003 12:24:35 GMT, "Lis" <liont…@ptd.net>
alt.support.sleep-disorder : – Hide quoted text — Show quoted text -> >You know, that’s really interesting about the iron connection….I was > >severely anemic as a child………. Time to get out the old mulit-vitamins, > >I suppose… > >I REALLY hope someone bites and does a decent study, and we get some benefit > >out of it. Not looking forward to that "gets worse in old age" thing. I’m > >only 41, fer gosh sakes. > >Lis > ><nos…@nospam.com> wrote in message > >news:qlc1pvce33n46eers1edu97gijtqenrk7f@4ax.com… > >> RESTLESS LEGS SYNDROME AND PERIODIC LIMB MOVEMENT DISORDER > >> The National Institute of Neurological Disorders and Stroke (NINDS), the > >> National Institute on Aging (NIA), the National Heart, Lung, and Blood > >> Institute, and the National Institute of Mental Health (NIMH) encourage > >> investigator-initiated research grant applications to study restless > >> legs syndrome (RLS) and periodic limb movement disorder (PLMD). The > >> etiologies of these disorders are unknown, although there is evidence > >> that central dopamine mechanisms are involved. Research should be aimed > >> at an understanding of the pathogenesis of RLS and PLMD that will lead > >> to new forms of treatment. The intent of this announcement is to > >> intensify investigator-initiated research, to attract new investigators > >> to the field, and to enhance interdisciplinary approaches to research in > >> these areas. > >> RESEARCH OBJECTIVES > >> Background > >> Restless legs syndrome is a common neurological disorder characterized > >> by unpleasant sensations of the legs and an urge to move them for > >> relief. Because symptoms are intensified by inactivity and lying down, > >> RLS patients often have difficulty falling asleep and staying asleep. > >> Left untreated, RLS causes exhaustion and fatigue, which can affect > >> occupational performance, social activities, and family life. Most > >> prevalence estimates are around 2-5% of the population, although many > >> more may be affected because the disorder is often not diagnosed. Severe > >> RLS is more common in the elderly, affecting an estimated 10-11%, > >> although symptoms may develop at any age. The etiology of RLS probably > >> involves central dopamine mechanisms, and both dopaminergic agents and > >> dopamine agonists have been used to treat symptoms. RLS is also > >> associated with iron deficiency, indicated by low ferritin levels. These > >> levels appear to follow a circadian cycle, and are at their lowest at > >> night when RLS symptoms are the worst. The frequency of RLS during late > >> stage pregnancy is increased, which may be related to iron deficiency. > >> Many people with RLS report a family history of the disorder, but the > >> exact mode of inheritance is unknown. > >> It has been estimated that about 80% of RLS patients also have periodic > >> limb movement disorder (PLMD), or nocturnal myoclonus, which is > >> characterized by repetitive stereotyped movements of the limbs, > >> primarily the legs, during sleep. These movements typically occur every > >> 20 to 40 seconds, and may be associated with repeated arousal, and > >> severely fragmented sleep. In a study of patients with insomnia, PLMD or > >> RLS was diagnosed in 33% of patients older than 60 years as compared to > >> 18% of those 40 to 60 years and 7% of those 20 to 40 years of age. Like > >> RLS, the etiology of PLMD may involve a central dopamine mechanism, > >> because it also responds to dopaminergic drugs. However, treatment with > >> dopaminergic agonists can augment the symptoms, possibly by a > >> continuation of the underlying progressive inhibition of dopaminergic > >> neuronal activity. Current investigations indicate that both RLS and > >> PLMD occur in a substantial number of patients suffering from > >> Parkinson’s disease and narcolepsy, two other disorders thought to > >> involve central dopamine mechanism. Greater understanding of the role of > >> dopamine systems in the etiology of these all of these disorders may > >> provide a key to new treatment and prevention strategies.
Response:
you only absorb about 10% of the Iron in a standard multi vitamin and coffee cuts you Iron absorbtion by 50%. Try something like Generic Niferex to really boost your iron level. Best to get your serum Ferritin checked before or shortly after you start iron therapy though. Hemoglobin levels of iron MEAN ABSOLUTELY NOTHING when it comes to PLMD. Many doc’s do not understand this. You must know you IRON STORAGE LEVELS as measured by serum ferritin. My hemoglobin levels are always fine thanks to my Niferex but my serum Ferritin was only 16 when it was measured. For PLMD they want you to get that level to 50. 20 is considered normal. On Sat, 18 Oct 2003 12:24:35 GMT, "Lis" <liont…@ptd.net> alt.support.sleep-disorder : – Hide quoted text — Show quoted text ->You know, that’s really interesting about the iron connection….I was >severely anemic as a child………. Time to get out the old mulit-vitamins, >I suppose… >I REALLY hope someone bites and does a decent study, and we get some benefit >out of it. Not looking forward to that "gets worse in old age" thing. I’m >only 41, fer gosh sakes. >Lis ><nos…@nospam.com> wrote in message >news:qlc1pvce33n46eers1edu97gijtqenrk7f@4ax.com… >> RESTLESS LEGS SYNDROME AND PERIODIC LIMB MOVEMENT DISORDER >> The National Institute of Neurological Disorders and Stroke (NINDS), the >> National Institute on Aging (NIA), the National Heart, Lung, and Blood >> Institute, and the National Institute of Mental Health (NIMH) encourage >> investigator-initiated research grant applications to study restless >> legs syndrome (RLS) and periodic limb movement disorder (PLMD). The >> etiologies of these disorders are unknown, although there is evidence >> that central dopamine mechanisms are involved. Research should be aimed >> at an understanding of the pathogenesis of RLS and PLMD that will lead >> to new forms of treatment. The intent of this announcement is to >> intensify investigator-initiated research, to attract new investigators >> to the field, and to enhance interdisciplinary approaches to research in >> these areas. >> RESEARCH OBJECTIVES >> Background >> Restless legs syndrome is a common neurological disorder characterized >> by unpleasant sensations of the legs and an urge to move them for >> relief. Because symptoms are intensified by inactivity and lying down, >> RLS patients often have difficulty falling asleep and staying asleep. >> Left untreated, RLS causes exhaustion and fatigue, which can affect >> occupational performance, social activities, and family life. Most >> prevalence estimates are around 2-5% of the population, although many >> more may be affected because the disorder is often not diagnosed. Severe >> RLS is more common in the elderly, affecting an estimated 10-11%, >> although symptoms may develop at any age. The etiology of RLS probably >> involves central dopamine mechanisms, and both dopaminergic agents and >> dopamine agonists have been used to treat symptoms. RLS is also >> associated with iron deficiency, indicated by low ferritin levels. These >> levels appear to follow a circadian cycle, and are at their lowest at >> night when RLS symptoms are the worst. The frequency of RLS during late >> stage pregnancy is increased, which may be related to iron deficiency. >> Many people with RLS report a family history of the disorder, but the >> exact mode of inheritance is unknown. >> It has been estimated that about 80% of RLS patients also have periodic >> limb movement disorder (PLMD), or nocturnal myoclonus, which is >> characterized by repetitive stereotyped movements of the limbs, >> primarily the legs, during sleep. These movements typically occur every >> 20 to 40 seconds, and may be associated with repeated arousal, and >> severely fragmented sleep. In a study of patients with insomnia, PLMD or >> RLS was diagnosed in 33% of patients older than 60 years as compared to >> 18% of those 40 to 60 years and 7% of those 20 to 40 years of age. Like >> RLS, the etiology of PLMD may involve a central dopamine mechanism, >> because it also responds to dopaminergic drugs. However, treatment with >> dopaminergic agonists can augment the symptoms, possibly by a >> continuation of the underlying progressive inhibition of dopaminergic >> neuronal activity. Current investigations indicate that both RLS and >> PLMD occur in a substantial number of patients suffering from >> Parkinson’s disease and narcolepsy, two other disorders thought to >> involve central dopamine mechanism. Greater understanding of the role of >> dopamine systems in the etiology of these all of these disorders may >> provide a key to new treatment and prevention strategies.
Response:
You know, that’s really interesting about the iron connection….I was severely anemic as a child………. Time to get out the old mulit-vitamins, I suppose… I REALLY hope someone bites and does a decent study, and we get some benefit out of it. Not looking forward to that "gets worse in old age" thing. I’m only 41, fer gosh sakes. Lis <nos…@nospam.com> wrote in message
news:qlc1pvce33n46eers1edu97gijtqenrk7f@4ax.com… – Hide quoted text — Show quoted text -> RESTLESS LEGS SYNDROME AND PERIODIC LIMB MOVEMENT DISORDER > The National Institute of Neurological Disorders and Stroke (NINDS), the > National Institute on Aging (NIA), the National Heart, Lung, and Blood > Institute, and the National Institute of Mental Health (NIMH) encourage > investigator-initiated research grant applications to study restless > legs syndrome (RLS) and periodic limb movement disorder (PLMD). The > etiologies of these disorders are unknown, although there is evidence > that central dopamine mechanisms are involved. Research should be aimed > at an understanding of the pathogenesis of RLS and PLMD that will lead > to new forms of treatment. The intent of this announcement is to > intensify investigator-initiated research, to attract new investigators > to the field, and to enhance interdisciplinary approaches to research in > these areas. > RESEARCH OBJECTIVES > Background > Restless legs syndrome is a common neurological disorder characterized > by unpleasant sensations of the legs and an urge to move them for > relief. Because symptoms are intensified by inactivity and lying down, > RLS patients often have difficulty falling asleep and staying asleep. > Left untreated, RLS causes exhaustion and fatigue, which can affect > occupational performance, social activities, and family life. Most > prevalence estimates are around 2-5% of the population, although many > more may be affected because the disorder is often not diagnosed. Severe > RLS is more common in the elderly, affecting an estimated 10-11%, > although symptoms may develop at any age. The etiology of RLS probably > involves central dopamine mechanisms, and both dopaminergic agents and > dopamine agonists have been used to treat symptoms. RLS is also > associated with iron deficiency, indicated by low ferritin levels. These > levels appear to follow a circadian cycle, and are at their lowest at > night when RLS symptoms are the worst. The frequency of RLS during late > stage pregnancy is increased, which may be related to iron deficiency. > Many people with RLS report a family history of the disorder, but the > exact mode of inheritance is unknown. > It has been estimated that about 80% of RLS patients also have periodic > limb movement disorder (PLMD), or nocturnal myoclonus, which is > characterized by repetitive stereotyped movements of the limbs, > primarily the legs, during sleep. These movements typically occur every > 20 to 40 seconds, and may be associated with repeated arousal, and > severely fragmented sleep. In a study of patients with insomnia, PLMD or > RLS was diagnosed in 33% of patients older than 60 years as compared to > 18% of those 40 to 60 years and 7% of those 20 to 40 years of age. Like > RLS, the etiology of PLMD may involve a central dopamine mechanism, > because it also responds to dopaminergic drugs. However, treatment with > dopaminergic agonists can augment the symptoms, possibly by a > continuation of the underlying progressive inhibition of dopaminergic > neuronal activity. Current investigations indicate that both RLS and > PLMD occur in a substantial number of patients suffering from > Parkinson’s disease and narcolepsy, two other disorders thought to > involve central dopamine mechanism. Greater understanding of the role of > dopamine systems in the etiology of these all of these disorders may > provide a key to new treatment and prevention strategies.
Response:
RESTLESS LEGS SYNDROME AND PERIODIC LIMB MOVEMENT DISORDER The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute on Aging (NIA), the National Heart, Lung, and Blood Institute, and the National Institute of Mental Health (NIMH) encourage investigator-initiated research grant applications to study restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). The etiologies of these disorders are unknown, although there is evidence that central dopamine mechanisms are involved. Research should be aimed at an understanding of the pathogenesis of RLS and PLMD that will lead to new forms of treatment. The intent of this announcement is to intensify investigator-initiated research, to attract new investigators to the field, and to enhance interdisciplinary approaches to research in these areas. RESEARCH OBJECTIVES Background Restless legs syndrome is a common neurological disorder characterized by unpleasant sensations of the legs and an urge to move them for relief. Because symptoms are intensified by inactivity and lying down, RLS patients often have difficulty falling asleep and staying asleep. Left untreated, RLS causes exhaustion and fatigue, which can affect occupational performance, social activities, and family life. Most prevalence estimates are around 2-5% of the population, although many more may be affected because the disorder is often not diagnosed. Severe RLS is more common in the elderly, affecting an estimated 10-11%, although symptoms may develop at any age. The etiology of RLS probably involves central dopamine mechanisms, and both dopaminergic agents and dopamine agonists have been used to treat symptoms. RLS is also associated with iron deficiency, indicated by low ferritin levels. These levels appear to follow a circadian cycle, and are at their lowest at night when RLS symptoms are the worst. The frequency of RLS during late stage pregnancy is increased, which may be related to iron deficiency. Many people with RLS report a family history of the disorder, but the exact mode of inheritance is unknown. It has been estimated that about 80% of RLS patients also have periodic limb movement disorder (PLMD), or nocturnal myoclonus, which is characterized by repetitive stereotyped movements of the limbs, primarily the legs, during sleep. These movements typically occur every 20 to 40 seconds, and may be associated with repeated arousal, and severely fragmented sleep. In a study of patients with insomnia, PLMD or RLS was diagnosed in 33% of patients older than 60 years as compared to 18% of those 40 to 60 years and 7% of those 20 to 40 years of age. Like RLS, the etiology of PLMD may involve a central dopamine mechanism, because it also responds to dopaminergic drugs. However, treatment with dopaminergic agonists can augment the symptoms, possibly by a continuation of the underlying progressive inhibition of dopaminergic neuronal activity. Current investigations indicate that both RLS and PLMD occur in a substantial number of patients suffering from Parkinson
